Clinical Trial Update: First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy Participants [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of VH4011499 in healthy participants assessed safety, tolerability, and pharmacokinetics; the trial is completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• VH4011499

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-04-01